Literature DB >> 26768563

Evaluating interventions for Ebola: The need for randomized trials.

Thomas R Fleming1, Susan S Ellenberg2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26768563      PMCID: PMC4767552          DOI: 10.1177/1740774515616944

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  22 in total

Review 1.  The combination of randomized and historical controls in clinical trials.

Authors:  S J Pocock
Journal:  J Chronic Dis       Date:  1976-03

2.  Ebola in Freetown area, Sierra Leone--a case study of 581 patients.

Authors:  Rashid Ansumana; Kathryn H Jacobsen; Foday Sahr; M'baimba Idris; Henry Bangura; Mohamed Boie-Jalloh; Joseph M Lamin; Santigie Sesay
Journal:  N Engl J Med       Date:  2014-12-24       Impact factor: 91.245

3.  Clinical illness and outcomes in patients with Ebola in Sierra Leone.

Authors:  John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry
Journal:  N Engl J Med       Date:  2014-10-29       Impact factor: 91.245

4.  Addressing missing data in clinical trials.

Authors:  Thomas R Fleming
Journal:  Ann Intern Med       Date:  2011-01-18       Impact factor: 25.391

5.  Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

Authors:  Alejandro Dorenbaum; Coleen K Cunningham; Richard D Gelber; Mary Culnane; Lynne Mofenson; Paula Britto; Claire Rekacewicz; Marie-Louise Newell; Jean Francois Delfraissy; Bethann Cunningham-Schrader; Mark Mirochnick; John L Sullivan
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

6.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

7.  Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

8.  Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

9.  Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Authors:  Ana Maria Henao-Restrepo; Ira M Longini; Matthias Egger; Natalie E Dean; W John Edmunds; Anton Camacho; Miles W Carroll; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Stefanie Hossmann; Mandy Kader Kondé; Souleymane Kone; Eeva Kuisma; Myron M Levine; Sema Mandal; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; Conall H Watson; Sakoba Kéïta; Marie Paule Kieny; John-Arne Røttingen
Journal:  Lancet       Date:  2015-08-03       Impact factor: 79.321

10.  Decreased Ebola Transmission after Rapid Response to Outbreaks in Remote Areas, Liberia, 2014.

Authors:  Kim A Lindblade; Francis Kateh; Thomas K Nagbe; John C Neatherlin; Satish K Pillai; Kathleen R Attfield; Emmanuel Dweh; Danielle T Barradas; Seymour G Williams; David J Blackley; Hannah L Kirking; Monita R Patel; Monica Dea; Mehran S Massoudi; Kathleen Wannemuehler; Albert E Barskey; Shauna L Mettee Zarecki; Moses Fomba; Steven Grube; Lisa Belcher; Laura N Broyles; T Nikki Maxwell; Jose E Hagan; Kristin Yeoman; Matthew Westercamp; Joseph Forrester; Joshua Mott; Frank Mahoney; Laurence Slutsker; Kevin M DeCock; Tolbert Nyenswah
Journal:  Emerg Infect Dis       Date:  2015-10       Impact factor: 6.883

View more
  10 in total

1.  A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

Authors:  Richard T Davey; Lori Dodd; Michael A Proschan; James Neaton; Jacquie Neuhaus Nordwall; Joseph S Koopmeiners; John Beigel; John Tierney; H Clifford Lane; Anthony S Fauci; Moses B F Massaquoi; Foday Sahr; Denis Malvy
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

Review 2.  Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls.

Authors:  Dietrich Haubenberger; David B Clifford
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 3.  Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research.

Authors:  W Charles Huskins; Vance G Fowler; Scott Evans
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

4.  Rigorous Clinical Trial Design in Public Health Emergencies Is Essential.

Authors:  Susan S Ellenberg; Gerald T Keusch; Abdel G Babiker; Kathryn M Edwards; Roger J Lewis; Jens D Lundgren; Charles D Wells; Fred Wabwire-Mangen; Keith P W J McAdam
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

Review 5.  Design of vaccine efficacy trials during public health emergencies.

Authors:  Natalie E Dean; Pierre-Stéphane Gsell; Ron Brookmeyer; Victor De Gruttola; Christl A Donnelly; M Elizabeth Halloran; Momodou Jasseh; Martha Nason; Ximena Riveros; Conall H Watson; Ana Maria Henao-Restrepo; Ira M Longini
Journal:  Sci Transl Med       Date:  2019-07-03       Impact factor: 17.956

6.  The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection.

Authors:  Richard T Davey; Lori Dodd; Michael Proschan; Peter Jahrling; Lisa Hensley; Elizabeth Higgs; H Clifford Lane
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

7.  Resist the Temptation of Response-Adaptive Randomization.

Authors:  Michael Proschan; Scott Evans
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

8.  Designing & Conducting Trials To Reliably Evaluate HIV Prevention Interventions.

Authors:  Thomas R Fleming; Victor DeGruttola; Deborah Donnell
Journal:  Stat Commun Infect Dis       Date:  2019-07-18

9.  Monitoring clinical trials in infectious diseases.

Authors:  David L DeMets; Thomas R Fleming; Susan S Ellenberg
Journal:  J Allergy Infect Dis       Date:  2021

10.  Next steps for efficacy evaluation in clinical trials of COVID-19 vaccines.

Authors:  Hu-Dachuan Jiang; Li Zhang; Jing-Xin Li; Feng-Cai Zhu
Journal:  Engineering (Beijing)       Date:  2021-05-19       Impact factor: 7.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.